The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis have?
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis has 62 citations in the OpenAlex counts ScholarIQ stores.
When was The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis published?
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis has 2007 year in the ScholarIQ index.
What is the open-access status of The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis?
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis has bronze oa status in the ScholarIQ index.
What is the DOI of The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis?
The DOI for The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis is on the source record.
What is the PMID of The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis?
The PMID for The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis is on the source record.
What is the OpenAlex record for The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis?
The OpenAlex for The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis is on the source record.